These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 410226)

  • 1. Circulating anticoagulant against factor XI and thrombocytopenia with platelet aggregation inhibition in systemic lupus erythematosus.
    Leone G; Accorra F; Boni P
    Acta Haematol; 1977; 58(4):240-5. PubMed ID: 410226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating anticoagulant against factors XI and XII together with massive spontaneous platelet aggregation.
    Cronberg S; Nilsson IM
    Scand J Haematol; 1973; 10(4):309-14. PubMed ID: 4587560
    [No Abstract]   [Full Text] [Related]  

  • 3. Circulating anticoagulant against Factor XII and platelet antibodies in systemic lupus erythematosus.
    Gandolfo GM; Afeltra A; Amoroso A; Biancolella F; Ferri GM
    Acta Haematol; 1977; 57(3):135-42. PubMed ID: 402772
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelet autoantibodies detected by immunoblotting in systemic lupus erythematosus: association with the lupus anticoagulant, and with history of thrombosis and thrombocytopenia.
    Jouhikainen T; Kekomäki R; Leirisalo-Repo M; Bäcklund T; Myllylä G
    Eur J Haematol; 1990 Apr; 44(4):234-9. PubMed ID: 2111779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Systemic lupus erythematosus manifested by thrombophlebitis of the lower limbs].
    Olive D; André E; Brocard O; Labrude P; Alexandre P
    Arch Fr Pediatr; 1979; 36(8):807-11. PubMed ID: 539874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A circulating anticoagulant directed against factor XIa in systemic lupus erythematosus.
    DiSabatino CA; Clyne LP; Malawista SE
    Arthritis Rheum; 1979 Oct; 22(10):1135-8. PubMed ID: 486223
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants.
    Glueck HI; Kant KS; Weiss MA; Pollak VE; Miller MA; Coots M
    Arch Intern Med; 1985 Aug; 145(8):1389-95. PubMed ID: 3927865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications.
    Nojima J; Suehisa E; Kuratsune H; Machii T; Koike T; Kitani T; Kanakura Y; Amino N
    Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of a platelet bypass mechanism in the clotting system using an acquired anticoagulant.
    Firkin BG; Booth P; Hendrix L; Howard MA
    Am J Hematol; 1978; 5(2):81-92. PubMed ID: 736036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of lupus anticoagulant, autoimmune hemolysis, thrombocytopenia and disorders of platelet function in unselected patients with SLE].
    Söhngen D; Specker C; Wehmeier A; Kiefel V; Rathmer L; Söhngen R; Schneider W
    Beitr Infusionsther; 1992; 30():469-73. PubMed ID: 1284763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Report of two cases of circulating anticoagulant directed against factor xi (author's transl)].
    Vila M; Monasterio J; Arangüena PV; Valentin P; Pico M; Triginer J
    Sangre (Barc); 1978; 23(2):202-9. PubMed ID: 653555
    [No Abstract]   [Full Text] [Related]  

  • 12. Lupus anticoagulant and antiplatelet properties of human hybridoma autoantibodies.
    Rauch J; Meng QH; Tannenbaum H
    J Immunol; 1987 Oct; 139(8):2598-604. PubMed ID: 3116088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet function and coagulation profile in lupus erythematosus. Studies in 50 patients.
    Regan MG; Lackner H; Karpatkin S
    Ann Intern Med; 1974 Oct; 81(4):462-8. PubMed ID: 4213298
    [No Abstract]   [Full Text] [Related]  

  • 14. Circulating anticoagulants against factors IX and XI in systemic lupus erythematosus.
    Castro O; Farber LR; Clyne LP
    Ann Intern Med; 1972 Oct; 77(4):543-8. PubMed ID: 4642734
    [No Abstract]   [Full Text] [Related]  

  • 15. Circulating factor XI antibody and disseminated intravascular coagulation.
    Fischer DS; Clyne LP
    Arch Intern Med; 1981 Mar; 141(4):515-7. PubMed ID: 7212896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-factor XI circulating anticoagulant (author's transl)].
    Durán Suárez JR; Vilaseca J; Ordeig J; Triginer J
    Sangre (Barc); 1981; 26(5-A):631-7. PubMed ID: 7323919
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum factors releasing serotonin from normal platelets: relation to the manifestations of systemic lupus erythematosus.
    Ginsberg MH; O'Malley M
    Ann Intern Med; 1977 Nov; 87(5):564-7. PubMed ID: 921084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired factor XI inhibitor in systemic lupus erythematosus--case report and literature review.
    Bortoli R; Monticielo OA; Chakr RM; Palominos PE; Rohsig LM; Kohem CL; Xavier RM; Brenol JC
    Semin Arthritis Rheum; 2009 Aug; 39(1):61-5. PubMed ID: 18519152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of IgG bound to platelet membrane in patients with systemic lupus erythematosus].
    Acciaresi MS; Molinas FC
    Medicina (B Aires); 1983; 43(3):250-6. PubMed ID: 6672509
    [No Abstract]   [Full Text] [Related]  

  • 20. Platelet and plasma serotonin in glomerulonephritis. III: The nephritis of systemic lupus erythematosus.
    Parbtani A; Frampton G; Yewdall V; Kasai N; Cameron JS
    Clin Nephrol; 1980 Oct; 14(4):164-72. PubMed ID: 7428190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.